Epigenetic clocks estimate age by measuring reversible chemical changes to DNA known as epigenetic marks. These tools are highly effective for studying aging at the population level but are not validated for assessing individual health.
Epigenetic clocks are not designed to make medical claims about individuals and do not meet the standards required of common clinical tests. At the individual level, they can produce inconsistent or inaccurate results due to the dynamic nature of epigenetic changes, which are influenced by short-term factors such as diet, illness, environmental exposures, stress, and even time of day. As a result, a person’s estimated epigenetic age could vary substantially depending on when they are tested.
There are dozens of different epigenetic clocks, each developed for specific purposes like predicting chronological age, biological aging rate, or mortality risk. However, these clocks often yield conflicting results—even when applied to the same individual. Differences can also arise based on sample type: testing saliva versus blood from the same person may produce substantially different epigenetic age estimates. Additionally, original clock algorithms may not perform consistently as laboratory technologies evolve, and no universally accepted gold-standard method exists for generating or validating these clocks across research settings.
Scientists caution that reducing the complexity of aging—a process lacking a single agreed-upon definition—to a single number can be misleading. Epigenetic marks are shaped not only by lifestyle choices but also by social and historical factors, including trauma, discrimination, and early life adversity. On average, marginalized communities show signs of accelerated epigenetic aging, reflecting the biological impact of systemic inequities. If used by insurers to set premiums, epigenetic age estimates could penalize individuals for biological differences rooted in circumstances beyond their control, potentially worsening health disparities.
Despite these limitations, epigenetic clocks remain valuable research tools. Scientists have used them to identify that behaviors like calorie reduction, regular exercise, healthy diet, sufficient sleep, and avoiding smoking are associated with slower aging at the group level. Clocks have also aided in evaluating experimental interventions: rapamycin has been shown to reduce epigenetic age in human skin cells, and a thymus-regenerating treatment appeared to slow or reverse epigenetic aging after one year. However, all observed intervention effects have been documented only in aggregate data, not in individual responses.